SENORES PHARMACEUTICALS L

SENORES

Small Cap | Pharmaceuticals
825.3
+1.89 (+0.22%)

Stock price as on 06 Feb 2026 at 15:30 PM

Senores pharmaceuticals l share price update

As of the latest trading session, Senores Pharmaceuticals L share price is currently at ₹825.3, which is up by ₹1.89 from its previous closing. Today ...

Senores Pharmaceuticals L stock performance

Today’s low

₹812.75

Today’s high

₹836.75

₹825.3

52 week low

₹440.3

52 week high

₹876.5

₹825.3
Open
₹819.05
Previous close
₹823.40
Share volume
1,00,960
Total traded value (Lakh)
₹833.22
Upper circuit
₹988.05
Lower circuit
₹658.75

Senores Pharmaceuticals L fundamentals

Market cap (Cr)
₹3,800.80
P/E ratio (TTM)
275.9
Book value per share
₹155.05
Beta
1.24
Return on equity
0.84%
Earnings per share (TTM)
₹2.99
Dividend yield
0%
Net profit/quarter (Cr)
₹2.65

Senores Pharmaceuticals L financials

(Values in Cr)
Revenue
Net income

Particulars

Dec 25 (₹ value in crores)

Revenue

₹16.53

Operating expense

₹35.02

Net income

₹2.65

Net profit margin

16.03%

Earning per share

₹1.98

EBITDA

₹8.85

Effective tax rate

24.71%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹20.92

Operating expense

₹39.04

Net income

₹6.43

Net profit margin

30.73%

Earning per share

₹1.40

EBITDA

₹12.88

Effective tax rate

15.94%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹15.49

Operating expense

₹24.62

Net income

₹2.70

Net profit margin

17.43%

Earning per share

₹0.59

EBITDA

₹7.22

Effective tax rate

24.79%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹11.86

Operating expense

₹18.22

Net income

₹2.01

Net profit margin

16.94%

Earning per share

₹0.39

EBITDA

₹6.51

Effective tax rate

30.44%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹9.59

Operating expense

₹15.46

Net income

₹1.07

Net profit margin

11.15%

Earning per share

₹0.32

EBITDA

₹4.77

Effective tax rate

18.93%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹38.54

Operating expense

₹55.42

Net income

₹3.69

Net profit margin

9.57%

Earning per share

₹1.02

EBITDA

₹14.70

Effective tax rate

27.78%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹34.01

Operating expense

₹38.83

Net income

₹0.81

Net profit margin

2.38%

Earning per share

₹0.35

EBITDA

₹6.78

Effective tax rate

60.09%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹12.38

Operating expense

₹17.23

Net income

₹1.20

Net profit margin

9.69%

Earning per share

₹1.26

EBITDA

₹5.01

Effective tax rate

38.14%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹15.85

Operating expense

₹15.98

Net income

₹0.29

Net profit margin

1.82%

Earning per share

₹0.33

EBITDA

₹1.97

Effective tax rate

67.77%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹7.91

Operating expense

₹7.66

Net income

₹0.84

Net profit margin

10.61%

Earning per share

₹2.20

EBITDA

₹1.17

Effective tax rate

-109.99%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹170.72

Return on Equity (ROE)

11.78%

Return on Capital Employed (ROCE)

11.75%

Total debt to equity ratio

0.58

EBITDA margin

27.36%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹66.95

Return on Equity (ROE)

26.19%

Return on Capital Employed (ROCE)

12.04%

Total debt to equity ratio

1.28

EBITDA margin

20.7%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹46.36

Return on Equity (ROE)

20.54%

Return on Capital Employed (ROCE)

18.24%

Total debt to equity ratio

0.94

EBITDA margin

46.29%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹41.86

Return on Equity (ROE)

2.71%

Return on Capital Employed (ROCE)

3.33%

Total debt to equity ratio

0.4

EBITDA margin

17.08%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹153.74

Return on Equity (ROE)

0.84%

Return on Capital Employed (ROCE)

2.15%

Total debt to equity ratio

0.23

EBITDA margin

38.17%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹55.10

Return on Equity (ROE)

0.78%

Return on Capital Employed (ROCE)

2.56%

Total debt to equity ratio

0.78

EBITDA margin

19.94%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹39.66

Return on Equity (ROE)

3.3%

Return on Capital Employed (ROCE)

5.44%

Total debt to equity ratio

1.04

EBITDA margin

40.47%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹38.54

Return on Equity (ROE)

3.15%

Return on Capital Employed (ROCE)

4.51%

Total debt to equity ratio

0.43

EBITDA margin

15.51%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹24.91

Return on Equity (ROE)

8.87%

Return on Capital Employed (ROCE)

4.55%

Total debt to equity ratio

0.39

EBITDA margin

14.79%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹385.50

Total assets

₹1,226.86

Total liabilities

₹1,226.86

Total equity

₹812.24

Shares outstanding

₹4.60

Price to book ratio

₹3.73

Return on assets (%)

4.77%

Return on capital

5.24%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹13.06

Total assets

₹621.88

Total liabilities

₹621.88

Total equity

₹231.71

Shares outstanding

₹3.05

Price to book ratio

-

Return on assets (%)

5.05%

Return on capital

6.55%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.10

Total assets

₹131.05

Total liabilities

₹131.05

Total equity

₹45.49

Shares outstanding

₹0.98

Price to book ratio

-

Return on assets (%)

6.43%

Return on capital

7.94%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹3.21

Total assets

₹59.15

Total liabilities

₹59.15

Total equity

₹36.59

Shares outstanding

₹0.98

Price to book ratio

-

Return on assets (%)

1.67%

Return on capital

1.95%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹359.72

Total assets

₹834.09

Total liabilities

₹834.09

Total equity

₹707.97

Shares outstanding

₹4.60

Price to book ratio

₹3.73

Return on assets (%)

0.44%

Return on capital

0.46%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹10.45

Total assets

₹285.86

Total liabilities

₹285.86

Total equity

₹168.12

Shares outstanding

₹3.05

Price to book ratio

-

Return on assets (%)

0.28%

Return on capital

0.31%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.09

Total assets

₹111.71

Total liabilities

₹111.71

Total equity

₹38.92

Shares outstanding

₹0.98

Price to book ratio

-

Return on assets (%)

1.07%

Return on capital

1.21%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹1.40

Total assets

₹55.16

Total liabilities

₹55.16

Total equity

₹33.69

Shares outstanding

₹0.71

Price to book ratio

-

Return on assets (%)

1.23%

Return on capital

1.42%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹1.64

Total assets

₹14.95

Total liabilities

₹14.95

Total equity

₹9.46

Shares outstanding

₹0.38

Price to book ratio

-

Return on assets (%)

5.58%

Return on capital

6.35%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹70.57

Cash from operations

-₹36.75

Cash from investing

-₹429.48

Cash from financing

₹573.13

Net change in cash

₹97.73

Free cash flow

₹120.77

Particulars

Mar 24 (₹ value in crores)

Net income

₹24.94

Cash from operations

-₹23.22

Cash from investing

-₹54.23

Cash from financing

₹86.98

Net change in cash

₹7.05

Free cash flow

₹28.61

Particulars

Mar 23 (₹ value in crores)

Net income

₹12.43

Cash from operations

₹0.37

Cash from investing

-₹48.28

Cash from financing

₹46.25

Net change in cash

-₹3.11

Free cash flow

₹47.65

Particulars

Mar 22 (₹ value in crores)

Net income

₹1.14

Cash from operations

-₹10.30

Cash from investing

-₹24.44

Cash from financing

₹36.46

Net change in cash

₹1.57

Free cash flow

₹0.37

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹5.11

Cash from operations

-₹18.95

Cash from investing

-₹162.94

Cash from financing

₹532.62

Net change in cash

₹349.28

Free cash flow

₹30.16

Particulars

Mar 24 (₹ value in crores)

Net income

₹2.03

Cash from operations

-₹18.07

Cash from investing

-₹57.07

Cash from financing

₹86.68

Net change in cash

₹10.35

Free cash flow

₹1.19

Particulars

Mar 23 (₹ value in crores)

Net income

₹1.94

Cash from operations

-₹39.80

Cash from investing

-₹5.22

Cash from financing

₹47.07

Net change in cash

-₹1.56

Free cash flow

-₹31.42

Particulars

Mar 22 (₹ value in crores)

Net income

₹0.83

Cash from operations

-₹23.91

Cash from investing

-₹10.05

Cash from financing

₹33.87

Net change in cash

-₹0.23

Free cash flow

-₹23.43

Particulars

Mar 21 (₹ value in crores)

Net income

₹0.40

Cash from operations

-₹2.85

Cash from investing

-₹4.37

Cash from financing

₹8.49

Net change in cash

₹1.25

Free cash flow

-₹0.06

Senores Pharmaceuticals L technical summary

₹825.3
+ 0.23 ▲
16
Bearish
0
Bullish
5 Day815.6
10 Day809.6
12 Day808.8
20 Day808.4
26 Day808.1
50 Day801.2
100 Day771.7
200 Day703.2
5 Day813.3
10 Day800.2
12 Day803.5
20 Day805
26 Day814.2
50 Day806.8
100 Day776.6
200 Day686.4

820.97

PIVOT

First support
₹814.93
First resistance
₹829.43
Second support
₹806.47
Second resistance
₹835.47
Third support
₹800.43
Third resistance
₹843.93
RSI
54.88
ADX
15.56
MACD
-0.91
Williams % R
-28.68
Commodity Channel Index (CCI)
72.89
Date
05 Feb 2026
Same day
46,874
Week
55,200
Month
1,01,675
1 year
1.21
3 years
1.44
Over 1 month
-2.87%
Over 1 year
49.95%
Over 3 months
2.3%
Over 3 years
0%
Over 6 months
21.75%
Over 6 years
0%

Investment Returns

Over 1 Month2.87%
Over 3 Months2.3%
Over 6 Months21.75%
Over 1 Year49.95%

Senores Pharmaceuticals L Shareholding pattern


Public
41.53%
Promoter holdings
45.8%
FII
3.34%
DII
9.31%
Promoter shares
1.9%
Promoter sharesShareCategory

Swapnil Jatin Shah

35,53,531 (7.72%)

Shareholding of Promoter and Promoter Group

Ashokbhai Vijaysinh Barot

34,44,869 (7.48%)

Shareholding of Promoter and Promoter Group

Renosen Pharmaceuticals Private Limited

27,12,719 (5.89%)

Shareholding of Promoter and Promoter Group

Anar Swapnil Shah

22,94,500 (4.98%)

Shareholding of Promoter and Promoter Group

Aviraj Overseas Llc

18,95,190 (4.12%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Swapnil Jatin Shah35,53,531 (7.72%)Shareholding of Promoter and Promoter Group
Ashokbhai Vijaysinh Barot34,44,869 (7.48%)Shareholding of Promoter and Promoter Group
Renosen Pharmaceuticals Private Limited27,12,719 (5.89%)Shareholding of Promoter and Promoter Group
Anar Swapnil Shah22,94,500 (4.98%)Shareholding of Promoter and Promoter Group
Aviraj Overseas Llc18,95,190 (4.12%)Shareholding of Promoter and Promoter Group
Aditya Birla Sun Life Insurance Company Limited12,24,913 (2.66%)Public Shareholding
Sangeeta Mukur Barot10,42,955 (2.26%)Shareholding of Promoter and Promoter Group
Hsbc Mutual Fund - Hsbc Value Fund9,57,548 (2.08%)Public Shareholding
Manoj Prakash Sanghvi8,54,484 (1.86%)Public Shareholding
Ratnamani Marketing Private Limited8,38,000 (1.82%)Public Shareholding
Aviraj Group Llc6,84,750 (1.49%)Shareholding of Promoter and Promoter Group
Mahindra Manulife Large & Mid Cap Fund6,47,000 (1.4%)Public Shareholding
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund6,40,883 (1.39%)Public Shareholding
Astorne Capital Vcc - Arven6,27,714 (1.36%)Public Shareholding
Jayanti Mishrimal Sanghvi .5,67,823 (1.23%)Public Shareholding
Bishwanath Prasad Agrawal5,64,000 (1.22%)Public Shareholding
Jigar Prakash Sanghvi5,49,523 (1.19%)Public Shareholding
Espee Therapeutics Llp4,95,000 (1.07%)Shareholding of Promoter and Promoter Group
Jitendra Babulal Sanghvi4,88,516 (1.06%)Shareholding of Promoter and Promoter Group
Prakash Mishrimal Sanghvi4,76,190 (1.03%)Public Shareholding
Mukur Yogeshkumar Barot4,56,825 (0.99%)Shareholding of Promoter and Promoter Group
Shantaben Babulal Sanghvi3,28,569 (0.71%)Shareholding of Promoter and Promoter Group
Dhananjay Ashokkumar Barot3,12,689 (0.68%)Shareholding of Promoter and Promoter Group
Hemant Ishwarlal Modi62,000 (0.13%)Shareholding of Promoter and Promoter Group
Jatin Siddharthbhai Shah30,000 (0.07%)Shareholding of Promoter and Promoter Group
Pinky Jatin Shah30,500 (0.07%)Shareholding of Promoter and Promoter Group

About SENORES PHARMACEUTICALS L

Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre. Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in

Parent Organisation

Indian Private

NSE Symbol

SENORES

Founded

2017

SENORES PHARMACEUTICALS L CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)